E. Russi (Zurich, Switzerland), F. Mihaltan (Bucharest, Romania)
A community-based intravenous medication service has proven to be safe, effective and cost-effective for patients with acute respiratory illness I. Sulaiman, S. Lane, J. Cullen (Dublin, Ireland)
| |
Is newborn screening for cystic fibrosis cost-effective? J. Jarrett, M. Mugford, R. Iles, E. Sims (Norwich, Cambridge, Cawston, United Kingdom)
| |
The impact and costs of reimbursed smoking cessation using varenicline in Denmark J. Dollerup, P. B. Poulsen, P. Tønnesen (Ballerup, Gentofte, Denmark)
| |
Potential economic savings of early detection of COPD in general praksis in Denmark J. Dollerup, A. Løkke, P. B. Poulsen, G. Hansen, J. Lykke Jensen, J. Holt, B. Lavik, C. Suppli Ulrik, R. Dahl (Ballerup, Aarhus, Copenhagen, Rødovre, Hvidovre, Denmark)
| |
Cost-effectiveness of budesonide/formoterol added to tiotropium in COPD patients in Canada, Australia and Sweden N. Mittmann, P. Hernandez, C. Mellström, L. Brannman, T. Welte (Halifax, Canada; Lund, Sweden; , Germany)
| |
An integrated approach to domiciliary oxygen service improves quality of usage and cost effectiveness M. Bhattacharya, S. Channon, R. Mukherjee (Milton Keynes, Birmingham, United Kingdom)
| |
Palliative care and end of life decisions in chronic obstructive pulmonary disease A. Fahim, J. Kastelik (Cottingham, United Kingdom)
| |